31 03-2023 FDA approves twice-daily dosing option for presbyopia eye drop treatment The FDA has approved a twice-daily dosing option of pilocarpine HCl ophthalmic solution 1.25% (VUITY) for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. A second dose (one additional drop in each eye) may be administered 3 to 6 hours after the first dose. Presbyopia, or age-related blurry near vision, is a common and progressive […] Read More
